Public, Private Donors Put Up US$200-Plus Million for GHIT’s 2nd-Phase Work

Chieftains of Partner Drug Makers Also Joined Tokyo Press Conference on June 1 Donors of the Global Health Innovative Technology Fund (GHIT Fund) has pledged a total of over US$200 million for its second-phase projects aimed at developing new tools...read more